What is the level of liabilities of Health Sciences Group this year?
Health Sciences Group has a debt balance of 0 USD this year.
In 2024, Health Sciences Group's total liabilities amounted to 0 USD, a 0% difference from the 0 USD total liabilities in the previous year.
Health Sciences Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Health Sciences Group's financial stability, operational efficiency, and long-term viability.
By comparing Health Sciences Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Health Sciences Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Health Sciences Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Health Sciences Group has a debt balance of 0 USD this year.
The liabilities of Health Sciences Group have increased by 0% dropped compared to the previous year.
High liabilities can pose a risk for investors of Health Sciences Group, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Health Sciences Group has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Health Sciences Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Health Sciences Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Health Sciences Group include investments, acquisitions, operating costs, and sales development.
The liabilities of Health Sciences Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Health Sciences Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Health Sciences Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Sciences Group is expected to pay a dividend of 0 USD.
The current dividend yield of Health Sciences Group is .
Health Sciences Group pays a quarterly dividend. This is distributed in the months of .
Health Sciences Group paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Health Sciences Group is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Health Sciences Group from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
The last dividend was paid out on 9/30/2024.
In the year 2023, Health Sciences Group distributed 0 USD as dividends.
The dividends of Health Sciences Group are distributed in USD.
Our stock analysis for Health Sciences Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Sciences Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.